Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1 Gastrointestinal Neoplasms 1

Interventions

Drug Therapy 4 apatinib 3 Oxaliplatin 3 pemigatinib 2 pembrolizumab 2 cemiplimab 2 avelumab 2 atezolizumab 2 S 1 (combination) 2 Nivolumab 2 Leucovorin 2 Irinotecan 2 Folfox protocol 2 Fluorouracil 2 Everolimus 2 Erlotinib Hydrochloride 2 Endoscopic Mucosal Resection 2 Docetaxel 2 Capecitabine 2 CGX1321 2 vandetanib 1 titanium silicide 1 tepotinib 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sodium thiosulfate 1 selpercatinib 1 rucaparib 1 pralsetinib 1 ponatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Gastrointestinal Neoplasms × domatinostat × Clear all

NCT03812796 2019-02-05

EMERGE

Royal Marsden NHS Foundation Trust

Phase 2 Unknown

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡